SAB Biotherapeutics Ownership | Who Owns SAB Biotherapeutics?

Overview Forecast RevenueFinancials Chart

SAB Biotherapeutics Ownership Summary

SAB Biotherapeutics is owned by 301.51% institutional investors, 56.55% insiders. Vivo capital is the largest institutional shareholder, holding 122.87% of SABS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.45% of its assets in SAB Biotherapeutics shares.

SABS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	SAB Biotherapeutics	301.51%	56.55%	-258.06%
Sector	Healthcare Stocks	42.54%	10.83%	46.63%
Industry	Biotech Stocks	45.22%	10.75%	44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vivo capital	11.42M	122.87%	$22.95M
Ra capital management	4.40M	47.36%	$8.85M
Commodore capital lp	4.40M	47.36%	$8.85M
Woodline partners lp	2.85M	30.67%	$5.73M
Sessa capital im	2.20M	23.65%	$4.42M
Bvf inc/il	932.70K	10.04%	$1.87M
Sphera funds management	566.39K	6.09%	$1.14M
Vanguard group	365.75K	3.94%	$735.16K
Hb wealth management	307.50K	3.31%	$618.08K
Awm investment company	200.00K	2.15%	$402.00K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Vivo capital	11.42M	1.85%	$22.95M
Commodore capital lp	4.40M	0.43%	$8.85M
Sphera funds management	566.39K	0.24%	$1.14M
Ra capital management	4.40M	0.11%	$8.85M
Sessa capital im	2.20M	0.10%	$4.42M
Caxton	10.94K	0.10%	$21.98K
Bvf inc/il	932.70K	0.08%	$1.87M
Awm investment company	200.00K	0.04%	$402.00K
Woodline partners lp	2.85M	0.03%	$5.73M
First premier bank	18.99K	0.01%	$38.00K

Top Buyers

Holder	Shares	% Assets	Change
Vivo capital	11.42M	1.85%	11.42M
Commodore capital lp	4.40M	0.43%	4.40M
Ra capital management	4.40M	0.11%	4.40M
Woodline partners lp	2.85M	0.03%	2.85M
Sessa capital im	2.20M	0.10%	1.74M

Top Sellers

Holder	Shares	% Assets	Change
Silver oak securities	-	-	-20.19K
Xtx topco	-	-	-16.55K
Creative planning	-	-	-11.85K
Sachetta	-	-	-4.10K
Blackrock funding, inc. /de	6.34K	-	-667.00

New Positions

Holder	Shares	% Assets	Change	Value
Vivo capital	11.42M	1.85%	11.42M	$22.95M
Ra capital management	4.40M	0.11%	4.40M	$8.85M
Commodore capital lp	4.40M	0.43%	4.40M	$8.85M
Woodline partners lp	2.85M	0.03%	2.85M	$5.73M
Sphera funds management	566.39K	0.24%	566.39K	$1.14M

Sold Out

Holder	Change
Raymond james financial	-45.00
Sachetta	-4.10K
Creative planning	-11.85K
Xtx topco	-16.55K
Silver oak securities	-20.19K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	34	36.00%	28,023,938	1356.64%	301	70.37%	22	144.44%	2	-50.00%
Jun 30, 2025	25	-3.85%	1,923,784	-12.93%	20	3.66%	9	-18.18%	4	-33.33%
Mar 31, 2025	26	4.00%	2,209,552	-15.93%	23	2.95%	11	22.22%	6	-14.29%
Dec 31, 2024	25	4.17%	2,628,252	-16.34%	28	2.46%	9	28.57%	7	75.00%
Sep 30, 2024	24	14.29%	3,141,736	0.47%	33	2.97%	7	-	4	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	227.59K	2.45%	-4.97K
A4Investments SICAV SIF ACCI IlanaA2EURH	60.00K	0.58%	60.00K
Vanguard Institutional Extnd Mkt Idx Tr	51.43K	0.55%	2.76K
Fidelity Extended Market Index	43.08K	0.41%	-355.00
Fidelity Total Market Index	12.90K	0.12%	-
Fidelity Series Total Market Index	10.62K	0.10%	-
NT Ext Equity Mkt Idx Fd - L	8.64K	0.09%	-
Northern Trust Extended Eq Market Idx	8.64K	0.09%	-
Spartan Extended Market Index Pool E	8.36K	0.09%	356.00
Spartan Extended Market Index Pool F	9.22K	0.09%	355.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 07, 2023	Sullivan Eddie Joe	Chief Executive Officer	Buy	$1.53K
Nov 30, 2023	King Michael	CHIEF FINANCIAL OFFICER	Buy	$4.50K
Nov 29, 2023	Reich Samuel J	Executive Chairman	Buy	$9.84K
Sep 13, 2022	HAMILTON CHRISTINE E		Buy	$7.30K
Sep 07, 2022	Sullivan Eddie Joe	CHIEF EXECUTIVE OFFICER	Buy	$10.32K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q3	-	-
2024 Q2	-	-

SABS Ownership FAQ

Who Owns SAB Biotherapeutics?

SAB Biotherapeutics shareholders are primarily institutional investors at 301.51%, followed by 56.55% insiders and -258.06% retail investors. The average institutional ownership in SAB Biotherapeutics's industry, Biotech Stocks , is 45.22%, which SAB Biotherapeutics exceeds.

Who owns the most shares of SAB Biotherapeutics?

SAB Biotherapeutics’s largest shareholders are Vivo capital (11.42M shares, 122.87%), Ra capital management (4.4M shares, 47.36%), and Commodore capital lp (4.4M shares, 47.36%). Together, they hold 217.58% of SAB Biotherapeutics’s total shares outstanding.

Does Blackrock own SAB Biotherapeutics?

BlackRock is not among the top 10 institutional shareholders of SAB Biotherapeutics.

Who is SAB Biotherapeutics’s biggest shareholder by percentage of total assets invested?

Vivo capital is SAB Biotherapeutics’s biggest shareholder by percentage of total assets invested, with 1.85% of its assets in 11.42M SAB Biotherapeutics shares, valued at 22.95M$.

Who is the top mutual fund holder of SAB Biotherapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of SAB Biotherapeutics shares, with 2.45% of its total shares outstanding invested in 227.59K SAB Biotherapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools